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966Objective: Little is known about the impact of preoperative renal function stratified by estimated glomerular
filtration rate (eGFR) on outcomes of total aortic arch replacement (TAR). The current study addressed this issue
and identified a cutoff value of eGFR for the requirement of postoperative renal replacement therapy.
Methods: From January 2000 to May 2011, 229 consecutive patients who did not require preoperative hemo-
dialysis were retrospectively studied after elective TAR. Patients were grouped into the following categories:
those with normal renal function (eGFR>90 mL/min/1.73 m2; n ¼ 11) and those with mild (eGFR, 60-90
mL/min/1.73 m2; n ¼ 86), moderate (eGFR, 30-59 mL/min/1.73 m2; n ¼ 111), or severe (eGFR<30 mL/
min/1.73 m2; n ¼ 21) renal dysfunction. Linear trend tests demonstrated that the lower categories of eGFR
were associated with a higher age, hypertension, coronary artery disease, peripheral arterial disease, and a higher
EuroSCORE II.
Results: The overall hospital mortality was 2.2%. A lower categories of eGFR were an independent risk factor
for hospital mortality (odds ratio, 0.91; P¼ .002) and postoperative renal replacement therapy (odds ratio, 0.94;
P<.002). A cutoff value for the requirement of postoperative renal replacement therapy was 26.0 mL/min/1.73
m2. Patients in the lower categories of eGFR had significantly higher hospital mortality (P¼ .03) and more mor-
bidities, such as renal replacement therapy (P<.01), postoperative permanent neurologic deficits (P ¼ .013),
and prolonged mechanical ventilatory support (P<.01). Midterm survival and freedom from major adverse
cerebrocardiovascular events were worse across the levels of the lower categories of eGFR.
Conclusions: Preoperative eGFR is a strong predictor of short- and midterm outcomes in contemporary TAR.
(J Thorac Cardiovasc Surg 2014;147:966-72)Supplemental material is available online.
Short- and long-term outcomes of total aortic arch replace-
ment (TAR) have been improving over the past decade.1,2
However, the procedure is likely to be associated with
more visceral organ dysfunction than are other cardiac
procedures because the procedure is accompanied by
ischemia-reperfusion injury caused by the lower body cir-
culatory arrest. The overall incidence of acute kidney injury
after aortic surgery has been reported to be high comparede Division of Cardiovascular Surgery, Department of Surgery, Kobe Univer-
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The Journal of Thoracic and Cardiovascular Surgwith other cardiac operations.3,4 Patients with chronic
kidney disease, a universal independent risk factor for
short- and long-term outcomes according to risk adjustment
models,5 are at a higher risk for postoperative de novo renal
replacement therapy (RRT), such as continuous hemodiafil-
tration (CHDF) and/or hemodialysis (HD). Previous studies
also identified postoperative RRT as one of the risk factors
for mortality in thoracic aortic surgery6,7; therefore, we
believe that it is of considerable importance to determine
the risk factors for predicting the need for RRT.
The glomerular filtration rate (GFR) is considered to be
a more accurate measure of renal function than is the serum
creatinine level,8 and estimated GFR (eGFR) was shown to
be a reliable predictor of outcomes in patients with acute
myocardial infarction9 and major adverse cerebrocardio-
vascular events (MACCE) in a large community-based pop-
ulation.10 A worse outcome also has been reported in
patients with renal dysfunction not requiring dialysis who
underwent coronary artery bypass grafting (CABG).11
However, little is known about the prognostic utility of
eGFR in patients undergoing TAR. The aim of the present
study was to address this issue and to determine a preopera-
tive, clinically relevant cutoff value of eGFR that predicts
postoperative de novo RRT.ery c March 2014
Abbreviations and Acronyms
CABG ¼ coronary artery bypass grafting
CHDF ¼ continuous hemodiafiltration
eGFR ¼ estimated glomerular filtration rate
GFR ¼ glomerular filtration rate
HD ¼ hemodialysis
MACCE ¼ major adverse cerebrocardiovascular
events
OR ¼ odds ratio
RRT ¼ renal replacement therapy
TAR ¼ total aortic arch replacement
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DPATIENT PROFILES AND METHODS
This study was approved by our institutional review board, and the need
for individual consent was waived. We retrospectively studied 229 consecu-
tive patientswithamean ageof71.7 11.5yearswhohadundergone elective
TAR through amedian sternotomy between January 2000 andMay 2011 and
did not require preoperative HD. Preoperative creatinine levels were
measured, and the GFR was estimated from the Japanese equation
(eGFR [mL/min/1.73 m2] ¼ 194 3 [serum creatinine]1.094 3 [patient
age]0.287 3 0.739 [if patient is female]) because the estimation of eGFR
is limited bydifferences in creatinine generation among ethnicities.12 Patients
were grouped into the following categories: those with normal renal function
(eGFR>90mL/min/1.73m2; n¼ 11) and thosewithmild (eGFR, 60-90mL/
min/1.73m2; n¼ 86), moderate (eGFR, 30-59mL/min/1.73m2; n¼ 111), or
severe (eGFR<30 mL/min/1.73 m2; n ¼ 21) renal dysfunction.
Surgical Protocol
The details of TAR at our institute have been reported previously.1 The
cannulation site and type of arterial cannulation for cardiopulmonary by-
pass are particularly important. Both transesophageal echocardiography
and epiaortic ultrasoundwere routinely applied to investigate the ascending
aorta and to determine proper cannulation site.13 The ascending aorta or
aortic arch perfusion was selected in the majority of cases (n ¼ 216,
94.3%). A 24F dispersion arterial cannula (Duraflo II; Edwards Lifescien-
ces LLC, Irvine, Calif) was inserted near the aortic root with perfusion to-
ward the aortic valve in 123 (53.5%) patients with atherothrombotic aorta.
After the tympanic temperature had fallen to 20C to 23C and rectal tem-
perature below 30C, the aortic arch aneurysm was opened, and antegrade
selective cerebral perfusionwas initiated. A 14F or 16F balloon-tipped can-
nula was inserted from inside the aorta into the brachiocephalic artery, and
12F cannulas were positioned in the left common carotid and left subcla-
vian arteries. The distal aortic arch or the descending aorta was divided
from inside the aorta to avoid injury to the recurrent nerve during circula-
tory arrest to the lower body. A gelatin-impregnated quadrifurcated Dacron
graft (Gelweave; Vascutek Ltd, Terumo Corporation, Inchinnan Renfrew-
shire, Scotland, United Kingdom, or J Graft Shield Neo, Japan Lifeline, To-
kyo, Japan) or Triplex (Terumo Corporation, Tokyo, Japan) was used. After
completion of the distal anastomosis of the prosthetic graft, lower body cir-
culation was reinstituted through a branch graft, and the tympanic/rectal
temperature was rewarmed early. The proximal anastomosis of the graft
was completed, followed by coronary reperfusion. Finally, the aortic
arch vessels were reconstructed.
Indications for Postoperative RRT
The indications for RRT (CHDF/HD)were oliguria less than 0.5 mL/kg/
h, volume overload, refractory pulmonary edema despite high doses of di-
uretics for 6 to 12 hours, difficult-to-control hyperkalemia, and/ormetabolic
acidosis. CHDF was applied for patients with hemodynamic instability.The Journal of Thoracic and CaDefinitions of Permanent and Transient Neurologic
Deficit, Atherothrombotic Aorta, and MACCE
Using the definition of theMount Sinai group,14 we defined a permanent
neurologic deficit as the presence of deficits that persisted on hospital dis-
charge. We defined a transient neurologic deficit as delayed awakening,
transient loss of orientation, slurred language, agitation, poor response to
commands, or transient hemiparesis that recovered by the time of hospital
discharge. When a fragile and spiculated atheroma that exceeded 5 mm in
thickness was confirmed by computed tomography in the ascending aorta
or aortic arch but did not include the aneurysm itself, an ‘‘atherothrombotic
aorta’’ was diagnosed.15 MACCE were defined as death from any cause,
the presence of myocardial ischemic events, congestive heart failures, ar-
rhythmias requiring hospitalization (atrial fibrillation, pacemaker, or im-
plantable cardioverter-defibrillator), and neurologic deficits (stroke or
brain hemorrhage).
Statistical Analysis
Data were processed using SPSS 11.0 software (SPSS Inc, Chicago, Ill).
Continuous values are expressed as the mean  standard deviation. Data
were analyzed by the c2 test or Fisher’s exact test for categorical variables.
We assessed linear trends by the Cochran-Armitage test for dichotomous
outcomes and the Jonckheere-Terpstra test for continuous outcomes
(Tables 1 and 2). Stepwise logistic regression analysis was performed to
identify the risk factors for hospital mortality and RRT (Tables 3 and 4).
Clinically relevant variables with P<.05 on univariate analysis were incor-
porated into themultivariatemodels to identify significant independent fac-
tors predictive of postoperative RRT. Calculation of the area under the
curve of the receiver operating characteristics with a 95% confidence inter-
val was used to assess the most clinically useful level of eGFR for predict-
ing the need for postoperative RRT. A cutoff value for the highest
sensitivity and specificity was identified. Survival was assessed by the
Kaplan-Meier method. A Cox proportional hazard analysis, into which
all preoperative variables in the patient profiles were incorporated, was
used to determine the risk factors for late mortality.RESULTS
Patient profiles are shown in Table 1. There were 47
(20.5%) octogenarians in the cohort. All of the dissections
were chronic aortic dissection. One hundred eleven
(48.5%) patients had concurrent procedures: CABG in
75, aortic root operation in 25 (reimplantation ¼ 6, Bentall
procedure ¼ 5, sinotubular junction plication ¼ 13, partial
remodeling¼ 1), aortic valve replacement in 4, mitral valve
repair in 2, maze procedure in 8, and abdominal aortic re-
placement in 5. When we compared baseline patient pro-
files across the degree of preoperative eGFR, the patients
with lower categories of eGFR were significantly older,
had lower incidence of aortic dissection, and were more
likely to have hypertension, coronary artery disease, and pe-
ripheral artery disease. There were significant trends across
the quartile in the EuroSCORE II16 and Japan score,5 indi-
cating that patients with lower categories of eGFR were at
higher risk (Table 1).
The operation time and cardiopulmonary bypass time
were significantly longer in patients with lower categories
of eGFR. The results on mortality and morbidities are
shown in Table 2. Overall 30-day mortality was 0%, and
hospital mortality was 2.2% (5/229). The causes of deathrdiovascular Surgery c Volume 147, Number 3 967
TABLE 1. Patient profiles
Variables Total
Normal eGFR>90
(mL/min/1.73 m2)
Mild eGFR
dysfunction 60-90
Moderate eGFR
dysfunction 30-59
Severe eGFR
dysfunction<30
P
value
No. of patients, (%) 229 11 (4.7) 86 (36.9) 111 (47.6) 21 (9.0)
Age, y, mean  SD 71.7  11.5 45.0  20.8 70.7  10.9 74.3  7.4 76.7  4.2 .0001
Octogenarian 47 (20.5) 1 (9.1) 15 (17.4) 27 (24.3) 4 (19.0) .25
Male gender 175 (76.4) 6 (54.5) 66 (76.7) 86 (77.5) 17 (81.0) .32
Dissection 24 (10.5) 5 (45.5) 10 (11.6) 9 (8.1) 0 (0) .0038
Atherothrombotic aorta 35 (15.3) 0 (0) 12 (14.0) 19 (17.1) 4 (19.0) .21
Serum Cr level (mg/dL) 1.10  0.7 0.62  0.09 0.78  0.11 1.13  0.23 2.75  1.06 <.0001
eGFR (mL/min/1.73 m2) 56.9  19.9 101.1  10.3 71.4  7.5 48.0  7.9 20.0  6.6 <.0001
Diabetes mellitus 34 (14.8) 1 (9.1) 11 (12.8) 19 (17.1) 3 (14.3) .39
Hypertension 195 (85.2) 6 (54.5) 71 (82.6) 101 (91.0) 17 (81.0) .043
Dyslipidemia 91 (39.7) 1 (9.1) 35 (40.7) 46 (41.4) 9 (42.9) .301
History of smoking 160 (69.9) 7 (63.6) 62 (72.1) 79 (71.2) 12 (57.1) .58
Old cerebral infarction 17 (7.4) 0 (0) 3 (3.5) 14 (12.6) 0 (0) .19
Extracranial carotid artery stenosis 27 (11.8) 0 (0) 9 (10.5) 15 (13.5) 3 (14.3) .23
Coronary artery disease 75 (32.8) 1 (9.1) 21 (24.4) 42 (37.8) 11 (52.4) .0015
Left ventricular EF (40%) 11 (4.8) 0 (0) 4 (4.7) 6 (5.4) 1 (4.8%) .64
Chronic atrial fibrillation 13 (5.7) 0 (0) 7 (8.1) 5 (4.5) 1 (4.8) .54
Chronic obstructive pulmonary disease 22 (9.6) 0 (0) 8 (9.3) 10 (9.0) 4 (19.0) .25
Peripheral arterial disease 11 (4.8) 0 (0) 2 (2.3) 6 (5.4) 3 (14.3) .031
Concurrent procedure 111 (48.5) 4 (36.4) 39 (45.3) 55 (49.5) 13 (61.9) .16
EuroSCORE 7.3  2.7 3.6  2.7 6.9  2.4 7.6  2.6 9.1  2.1 .0004
EuroSCORE II 4.5  2.9 1.9  1.2 3.8  2.5 4.8  3.0 7.2  2.6 .0004
Japan score (30-d mortality) 4.9  2.8 2.8  2.1 4.2  1.8 4.9  2.7 8.8  3.7 <.0001
Japan score (30-d mortality þ complications) 22.2  10.0 17.1  10.4 20.3  8.5 21.5  8.0 36.6  13.5 <.0001
eGFR, Estimated glomerular filtration rate; SD, standard deviation; Cr, creatinine; EF, ejection fraction.
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D were bowel necrosis in 3 patients (severe eGFR, n ¼ 2;
moderate eGFR dysfunction, n ¼ 1), pulmonary dysfunc-
tion in 1 patient (severe eGFR dysfunction), and sepsis in
1 patient (mild eGFR dysfunction). Comparing the hospital
mortality across the quartile of eGFR, the most striking
increase was observed in patients with severe eGFR dys-
function (P ¼ .03). Serious complications of permanent
neurologic deficit and prolonged ventilation were observed
in a significantly greater number of patients with lower cat-
egories of eGFR (P¼ .013 and P<.01, respectively). Post-
operative renal failure requiring RRToccurred in 11 (4.8%)
patients; of these patients, 10 (4.4%) were supported by
CHDF and 4 (1.7%) by HD. As expected, the incidence
of postoperative RRT (CHDF/HD) was greater in patients
with lower categories of eGFR, particularly with severe
eGFR (P<.01).
Table 3 shows the univariate and multivariate analyses for
hospital mortality. Age, atherothrombotic aorta, serum creat-
inine level, eGFR, chronic obstructive pulmonary disease,
and operation time were identified as risk factors by univari-
ate analysis. By multivariate analysis, age (odds ratio [OR],
1.33; P ¼ .04) and a lower level of eGFR (OR, 0.91;
P¼ .002)were determined tobe risk factors for postoperative
hospital mortality, whereas serum creatinine level was not.
Table 4 shows the univariate and multivariate analyses
for postoperative RRT. Age, serum creatinine level,968 The Journal of Thoracic and Cardiovascular SurgeGFR, coronary artery disease, operation time, and mini-
mum tympanic temperature were identified as risk factors
by univariate analysis. However, neither lower body circu-
latory arrest time nor minimum rectal temperature was
a risk factor. By multivariate analysis, however, serum cre-
atinine level (OR, 4.2; P< .0001) and a lower level of
eGFR (OR, 0.94; P ¼ .002) were risk factors for postoper-
ative RRT. Details for the 11 patients requiring postopera-
tive RRT are shown in Table E1. Their mean age and
preoperative eGFR were 77.9  3.0 years old and 29.4
 23.4 mL/min/1.73 m2, respectively. Accordingly, the av-
erage EuroSCORE II and Japan scores were as high as 6.5
 3.4 and 9.5  4.8, respectively. Eight of the 11 patients
underwent concomitant CABGs, which was reflected by
a longer operation time (549.2  181.7 minutes) and car-
diopulmonary bypass time (200.8  65.5 minutes), al-
though the lower body circulatory arrest time was shorter
and body temperatures were lower when compared with
the overall patient group. Hospital mortality among pa-
tients with postoperative RRT was as high as 36.4% (4/
11) versus 0.4% (1/218) among patients without RRT
(P<.0001).
The area under the curve of receiver operating character-
istics for preoperative eGFR for predicting postoperative de
novo RRTwas 0.82 (P<.0001), and the best cutoff value of
preoperative eGFR for predicting postoperative RRT afterery c March 2014
TABLE 2. Operation characteristics, hospital mortality and postoperative complications
Variables Total
Normal eGFR>90
(mL/min/1.73 m2)
Mild eGFR
dysfunction 60-90
Moderate eGFR
dysfunction 30-59
Severe eGFR
dysfunction<30
P
value
No. of patients 229 11 (4.7) 86 (36.9) 111 (47.6) 21 (9.0)
Operation time (min) 415.1  136.1 413.5  160.6 403.1  140.3 412.0  119.3 481.2  177.3 .026
CPB time (min) 173.2  52.0 160.3  45.2 168.6  53.0 177.3  50.3 177.2  60.3 .052
Myocardial ischemic time (min) 77.2  39.6 77.7  31.9 75.8  46.8 78.8  36.3 74.3  32.4 .18
SCP time (min) 89.3  22.1 90.7  26.1 90.4  21.8 89.3  23.1 84.3  16.0 .82
Lower body circulatory arrest time (min) 38.8  12.1 41.0  13.7 38.3  11.4 40.2  12.2 31.0  14.7 .88
Minimum tympanic temperature (C) 21.5  1.7 22.0  2.0 21.8  1.5 21.3  1.5 20.4  2.3 1.00
Minimum rectal temperature (C) 25.9  2.3 26.8  1.8 26.3  2.1 25.7  2.1 24.5  3.3 1.00
Thirty-day mortality 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) NA
Hospital mortality 5 (2.2) 0 (0) 1 (1.2) 1 (0.9) 3 (14.3) .03
PND 6 (2.6) 0 (0) 0 (0) 4 (3.6) 2 (9.5) .013
TND 20 (8.7) 0 (0) 6 (7.0) 11 (9.9) 3 (14.3) .15
Mediastinitis 5 (2.2) 1 (9.1) 0 (0) 3 (2.7) 1 (4.8) .41
Prolonged ventilation (48 h) 30 (13.1) 0 (0) 8 (9.3) 10 (9.0) 12 (57.1) <.01
RRT 11 (4.8) 0 (0) 2 (2.3) 1 (0.9) 8 (38.1) <.01
Continuous hemodiafiltration 10 (4.4) 0 (0) 2 (2.3) 1 (0.9) 7 (33.3) <.01
Hemodialysis 4 (1.7) 0 (0) 2 (2.3) 0 (0) 2 (9.5) .47
Gastrointestinal tract (necrosis) 2 (0.9) 0 (0) 0 (0) 1 (0.9) 1 (4.8) .094
eGFR, Estimated glomerular filtration rate; CPB, cardiopulmonary bypass, SCP, selective cerebral perfusion, PND, permanent neurologic deficit, TND, transient neurologic
deficit; RRT, renal replacement therapy.
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DTAR was determined to be 26.0 mL/min/1.73 m2 (sensitiv-
ity, 72.7%; specificity, 95.8%).
A midterm follow-up was completed for 93% of the pa-
tients, and the mean follow-up period was 29.6  28.2
months (range, 0.3-114.8 months; median, 19.7 months).
Figure 1 shows the Kaplan-Meier survival curves for the pa-
tients stratified by the preoperative eGFR. The survival was
clearly stratified and worse across the lower categories of
eGFR. The Cox proportional hazard analysis (Table E2)
showed that atherothrombotic aorta, chronic obstructive
pulmonary disease, and lower eGFR were risk factors for
midterm mortality. In Figure E1, data are shown for free-
dom from MACCE, which was also stratified across the
levels of preoperative eGFR. However, no stratification ex-
isted for freedom from aorta-related death (figure not
shown).
DISCUSSION
This retrospective study determined that preoperative pa-
tient profiles and the short-term, and midterm outcomes af-
ter elective TAR were clearly stratified by universally used
eGFR, whereas creatinine level has significant limitations
in this role because the definition of renal insufficiency us-
ing serum creatinine level varies.
Preoperative renal dysfunction is one of the strongest risk
factors that predict poor short- and long-term outcomes;
these poor outcomes occurred more frequently in patients
with renal dysfunction not requiring dialysis that underwent
CABG.11 Recent literature demonstrated the risk factors for
postoperative acute kidney injury defined by RIFLE criteria
(RIFLE¼ risk, injury, failure, loss, end stage) after thoracicThe Journal of Thoracic and Caaortic surgery,17 and a higher RIFLE classification was as-
sociated with worse short-term outcomes. However, little
is known about the impact of preoperative renal function
on outcomes after TAR, which involves an ischemic insult
against the kidneys.
Previous studies and risk stratification systems like the
EuroSCORE and Japan score have used serum creatinine
as the preoperative determinant for the degree of renal fail-
ure. Serum creatinine is generally accepted to be an insen-
sitive indicator of renal function. Compared with creatinine
levels, eGFR has been noted as the most reliable index of
renal function according to the National Kidney Foundation
guidelines.8 The recently revised EuroSCORE II also uses
the creatinine clearance calculated by the Cockcroft-Gault
formula for the risk model in contemporary cardiac sur-
gery.16 In the current study, the Japanese formula for
eGFR developed by collaborators was applied to take into
consideration the differences in creatinine generation
among ethnicities.12 Patients with lower categories of
eGFR tended to be older, havemore comorbidities, and con-
sequently higher scores for the EuroSCORE II and Japan
scoring systems. These associations have been shown to
be similar even with different modes of cardiovascular
operations.11,18
Go and associates10 reported the close relationship be-
tween eGFR and MACCE in a large community-based pop-
ulation. Anavekar and associates9 demonstrated that even
mild renal disease, as assessed by eGFR, should be consid-
ered a major risk factor for cardiovascular complications
after a myocardial infarction. In the literature, other
researchers have demonstrated that mild renal dysfunctionrdiovascular Surgery c Volume 147, Number 3 969
TABLE 3. Risk factors for hospital mortality identified by univariate
and multivariate analysis
Variables
Hospital mortality
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Age, y, mean  SD 1.25 (1.03-1.54) .028 1.33 (1.01-1.74) .04
Octogenarian 6.14 (0.99-37.9) .051
Atherothrombotic
aorta
9.00 (1.44-56.0) .02 15.5 (0.82-291.7) .07
Serum Cr level
(mg/dL)
4.13 (2.09-8.14) <.0001 17.0 (0.79-366.5) .07
eGFR
(mL/min/1.73 m2)
0.92 (0.87-0.98) .005 0.91 (0.83-1.00) .02
Diabetes mellitus 0.57 (0.07-4.62) .60
Hypertension 0.69 (0.08-6.38) .74
Dyslipidemia 0.37 (0.04-3.39) .38
Smoking 0.28 (0.05-1.71) .17
Extracranial
carotid artery
stenosis
1.90 (0.21-17.7) .57
Coronary artery
disease
8.62 (0.95-78.5) .056
Left ventricular EF
(40%)
5.35 (0.55-52.4) .15
COPD 6.80 (1.07-43.1) .04 2.50 (0.13-47.8) .54
Concurrent procedure 4.37 (0.48-39.8) .19
Operation time (min) 1.01 (1.00-1.01) .017 1.01 (1.00-1.01) .10
CPB time (min) 1.01 (1.00-1.02) .48
Myocardial ischemic
time (min)
0.99 (0.96-1.02) .56
SCP time (min) 1.00 (0.97-1.04) .83
Lower body
circulatory
arrest time (min)
0.93 (0.85-1.02) .10
Minimum tympanic
temperature (C)
0.87 (0.50-1.55) .65
Minimum rectal
temperature (C)
1.00 (0.68-1.47) .98
Variables of sex (female), dissection, old cerebral infarction, peripheral arterial dis-
ease, and concurrent procedure were not tested because hospital mortality was not ob-
served in patients with the factors. OR, Odds ratio; CI, confidence interval; SD,
standard deviation; Cr, creatinine; eGFR, estimated glomerular filtration rate; EF,
ejection fraction; COPD, chronic obstructive pulmonary disease; CPB, cardiopulmo-
nary bypass; SCP, selective cerebral perfusion.
TABLE 4. Risk factors for postoperative renal replacement therapy
(CHDF, HD) identified by univariate and multivariate analysis
Variables
Postoperative renal replacement therapy
Univariate Multivariate
OR (95% CI) P OR (95% CI) P
Age, y, mean  SD 1.11 (1.00-1.23) .048 1.12 (0.98-1.28) .11
Octogenarian 1.52 (0.39-5.96) .55
Male gender 3.29 (0.41-26.3) .26
Serum Cr level
(mg/dL)
5.11 (2.55-10.2) <.0001 4.20 (2.12-8.30) <.0001
eGFR
(mL/min/1.73 m2)
0.93 (0.90-0.97) <.0001 0.94 (0.90-0.98) .002
Diabetes mellitus 0.57 (0.07-4.62) .60
Hypertension 1.75 (0.22-14.1) .60
Dyslipidemia 1.89 (0.56-6.41) .30
Smoking 0.50 (0.15-1.69) .26
Extracranial
carotid artery
stenosis
3.09 (0.77-12.5) .11
Coronary artery
disease
5.91 (1.52-23.0) .01 1.95 (0.38-9.88) .42
Chronic atrial
fibrillation
1.75 (0.21-14.8) .61
COPD 2.24 (0.45-11.1) .32
Concurrent
procedure
3.03 (0.78-11.7) .11
Operation time
(min)
1.01 (1.00-1.01) .002 1.00 (1.00-1.01) .08
CPB time (min) 1.01 (1.00-1.02) .07
Myocardial
ischemic time
(min)
1.00 (0.98-1.02) .91
SCP time (min) 0.98 (0.95-1.02) .34
Lower body
circulatory arrest
time (min)
0.96 (0.91-1.02) .20
Minimum tympanic
temperature (C)
0.53 (0.34-0.82) .005 0.73 (0.44-1.19) .20
Minimum rectal
temperature (C)
0.87 (0.68-1.12) .28
Variables of dissection, old cerebral infarction, and peripheral arterial disease were
not tested because renal replacement therapy was not observed in patients with the
factors. OR, Odds ratio; CI, confidence interval; SD, standard deviation; Cr, creati-
nine; eGFR, estimated glomerular filtration rate; COPD, chronic obstructive pulmo-
nary disease; CPB, cardiopulmonary bypass, SCP, selective cerebral perfusion.
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valve surgery, whereas in the current study, moderate dys-
function was the most prevalent type. Therefore, we should
pay more attention to patients undergoing TAR. As for hos-
pital mortality, we found no increase in patients with mild
and moderate renal dysfunction. However, hospital mortal-
ity was increased to as high as 14.3% in patients with severe
dysfunction. Hillis and associates11 confirmed that an eGFR
level of 60 mL/min/1.73 m2 (mild dysfunction) was the
most useful in predicting 30-day mortality in patients un-
dergoing CABG. There was no 30-day mortality in the cur-
rent study, and therefore we cannot compare the level of970 The Journal of Thoracic and Cardiovascular Surgpreoperative eGFR in predicting early mortality to previous
studies. However, a lower preoperative level of eGFR was
proven to be a risk factor for hospital mortality (OR, 0.91;
95% confidence interval, 0.83-1.00; P ¼ .02) by multivar-
iate analysis, whereas serum creatinine level was not. Renal
dysfunction requiring postoperative RRT leads to increased
postoperative mortality. Bove and associates19 reported that
hospital mortality was 40.9% in patients with acute renal
failure and increased to 63.8% when RRT was indicated.
With regard to thoracic aortic surgery involving deep hypo-
thermic circulatory arrest, both Estrera and associates7 andery c March 2014
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FIGURE 1. Survival curve across the quartile stratified by preoperative
estimated glomerular filtration rate (eGFR) showing survival at 36 months
after surgery of 100.0%  0% (normal eGFR), 94.5%  2.7% (mild),
80.8%  5.3% (moderate), and 35.4%  13.3% (severe eGFR dysfunc-
tion).
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DAugoustides and associates6 identified postoperative RRT
as one of the risk factors for mortality. In the current study,
hospital mortality among patients with postoperative RRT
was as high as 36.4% (4/11) versus 0.4% (1/218) among
patients without the therapy (P< .0001). Estimated GFR
(OR, 0.94; P ¼ .002) and serum creatinine level (OR, 4.2;
P<.0001) were risk factors for postoperative RRT accord-
ing to multivariate analysis. However, neither lower body
circulatory arrest time nor minimum rectal temperature,
which was supposed to have an impact on the degree of re-
nal ischemic insult, was a risk factor. The analysis suggests
that it might be difficult to prevent the postoperative deteri-
oration of renal function in patients with severe renal dys-
function by lowering the degree of the rectal temperature
alone. In comparison with eGFR, our data suggested that
creatinine level was also a strong predictor with regard to
postoperative renal dysfunction but was less sensitive for
predicting hospital mortality. We believe that eGFR could
be a more accurate predictor for comorbidities except renal
dysfunction than serum creatinine level inasmuch as eGFR
was calculated using 3 independent variables of gender,
age, and serum creatinine. Hence, we identified the impor-
tance of risk factors for predicting postoperative de novo
RRT and a cutoff value of preoperative eGFR predictive
of RRT. Eventually, we confirmed that eGFR was a risk fac-
tor for the requirement of de novo RRT, and an eGFR level
of 26 mL/min/1.73 m2 (severe dysfunction) was the critical
threshold below which RRTwas likely to be needed postop-
eratively. Although Englberger and associates20 reported
that deep hypothermic circulatory arrest and preoperative
serum creatinine were not risk factors for acute kidney in-
jury in thoracic aortic surgery, we confirmed that severe re-
nal dysfunction assessed by eGFR might deserve special
attention. The cutoff value is critical to the field of aortic
surgery because the procedure induces renal ischemia dur-
ing the distal anastomosis. The finding will help surgeons toThe Journal of Thoracic and Cabetter identify patients at risk of de novo RRTafter TAR and
perform additional perioperative renal protection, such as
lower body perfusion during distal anastomosis21 or phar-
macologic intervention. Hybrid thoracic endovascular aor-
tic repair is expected to be an alternative to open surgery
in this era. However, Benedetto and associates22 failed to
supports the superiority of hybrid procedure relative to
open surgery using a meta-analysis. The selection remains
controversial.
With regard to morbidities, lower categories of eGFR
were significantly associated with more permanent neuro-
logic deficit and prolonged ventilation. Zierer and associ-
ates23 demonstrate that unilateral antegrade cerebral
perfusion offers at least equal brain protection as bilateral
antegrade cerebral perfusion by reducing the incidence of
embolism arising from surgical manipulation on the arch
vessels. Inasmuch as patients with lower categories of
eGFR have greatly accelerated vascular disease and
a very high cardiac risk,24 it might be one of the alternatives
to bilateral perfusion for brain protection so long as the cir-
cle of Wills in the brain is preserved.
Both midterm survival and freedom from MACCE were
compromised at the lower categories of eGFR. The Cox
proportional hazard analysis determined that atherothrom-
botic aorta, preoperative lower categories of eGFR, and
chronic obstructive pulmonary disease had an adverse im-
pact on midterm mortality. Our previous study also deter-
mined that patients with atherothrombotic aorta (shaggy
aorta) had decreased midterm survival compared with pa-
tients without atherothrombotic aorta.15 Taken together,
our data have elucidated that preoperative eGFR could
play a pivotal role in predicting outcomes after contempo-
rary TAR.Limitations
This is a retrospective study from a single center. The lo-
gistic regression analysis for hospital mortality was limited
by the small number of events, because our surgical ap-
proach generally provided satisfactory outcomes. Patients
requiring preoperative HD were excluded because of the
small number of these cases (n ¼ 4, no hospital mortality).
The completion of midterm follow-up was relatively low
(93%) and the mean follow-up period was short (29.6 
28.2 months; range, 0.3-114.8 months; median, 19.7
months).CONCLUSIONS
Hospital mortality in patients requiring postoperative
RRT was quite high. Preoperative eGFR was a strong pre-
dictor for short-term and midterm outcomes in TAR. Pa-
tients with severe renal dysfunction (eGFR <30) and
associated preoperative comorbidities may be predisposed
to adverse outcomes after TAR.rdiovascular Surgery c Volume 147, Number 3 971
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FIGURE E1. Freedom from major adverse cerebrocardiovascular events
across the quartile stratified by preoperative estimated glomerular filtration
rate (eGFR) showing the freedom at 36 months after surgery of 100% 
0% (normal eGFR), 91.2%  3.5% (mild), 78.0%  5.6% (moderate),
and 30.3%  12.3% (severe eGFR dysfunction).
TABLE E1. Details for patients who required postoperative RRT
No. Age Sex
EuroSCORE
II
Japan
score
Preop
Cr
Preop
eGFR
Concomitant
procedure
Op
time
CPB
time
CA
time
Min
tympanic
temp (C)
Min
rectal
temp (C)
Postop de
novo RRT
Outcome at
discharge
Causes
of death
1 77 M 5.3 10.2 4.2 11.6 No 580 154 27 20.0 28.5 CHDF Alive
2 84 M 11.8 16.7 4.5 10.5 CABG 605 178 30 20.0 26.0 CHDF Death Bowel necrosis
3 79 M 6.4 4.0 0.78 72.6 CABG 840 185 45 20.3 27.3 CHDF/HD Death Sepsis
4 76 M 9.6 8.3 2.1 25.4 CABG 425 160 35 19.8 20.8 CHDF Alive
5 79 M 10.1 15.5 3.0 16.4 CABG 905 227 41 19.2 25.4 HD Alive
6 73 F 1.9 2.2 0.64 68.2 CABG 505 263 30 18.4 28.0 CHDF/HD Alive
7 75 M 3.4 8.0 2.6 19.9 No 300 143 28 19.0 24.2 CHDF Alive
8 78 M 8.6 12.6 2.0 26.0 CABG 556 368 63 19.7 21.6 CHDF Alive
9 80 M 8.3 12.8 4.1 11.8 CABG 464 157 2 21.7 24.6 CHDF/HD Death Pulmonary
10 80 M 2.3 4.0 1.1 51.2 CABG 422 178 40 20.7 26.3 CHDF Alive
11 76 M 3.5 10.0 4.7 10.3 No 439 196 0 22.1 23.9 CHDF Death Bowel necrosis
RRT, Renal replacement therapy; M, male; F, female; Cr, creatinine; eGFR, estimated glomerular filtration rate; Op, operation; CPB, cardiopulmonary bypass; CA, circulatory
arrest; Min, minimum; CABG, coronary artery bypass grafting; CHDF, continuous hemodiafiltration; HD, hemodialysis.
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TABLE E2. Cox proportional hazard analysis
Variables OR (95% CI) P
Age 1.07 (1.00-1.15) .06
Female 1.37 (0.55-3.39) .50
Dissection 1.81 (0.20-16.1) .60
Atherothrombotic aorta 3.08 (1.27-7.46) .01
eGFR (mL/min/1.73 m2) 0.95 (0.93-0.97) <.0001
Diabetes mellitus 1.21 (0.46-3.21) .70
Hypertension 1.06 (0.38-2.96) .92
Dyslipidemia 0.83 (0.38-1.82) .64
History of smoking 0.91 (0.39-2.13) .83
Old cerebral infarction 0.79 (0.17-3.77) .77
Extracranial carotid artery stenosis 0.47 (0.13-1.66) .24
Coronary artery disease (CABG) 1.63 (0.47-5.59) .44
Low left ventricular EF (40%) 2.11 (0.64-6.99) .22
COPD 3.25 (1.24-8.47) .02
Peripheral arterial disease 0.76 (0.21-2.81) .68
Concurrent procedure 1.04 (0.28-3.80) .96
eGFR, Estimated glomerular filtration rate; CABG, coronary artery bypass grafting,
EF, ejection fraction; COPD, chronic obstructive pulmonary disease; OR, odds ratio;
CI, confidence interval.
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